Transaction details
On February 5, 2026, director John Rodney Messick executed a sale of 2,500 shares of Orrstown Financial Services, Inc. (NASDAQ: ORRF) at a per-share price of $38.62, producing proceeds of $96,550. The sale reduced his immediately held common stock position but left him with continued ownership in the company.
Post-sale holdings and vesting schedule
Following the disposition, Messick directly holds 7,167 shares of Orrstown Financial Services common stock. In addition to those shares, he directly owns 3,500 shares of common restricted stock, which are scheduled to vest over the next 18 months. The restricted-share vesting timeline remains an ongoing element of his overall stake in the company.
Quarterly results
Orrstown Financial Services reported fourth-quarter 2025 results that exceeded analysts' expectations on both earnings and revenue. The company posted earnings per share of $1.11, ahead of the forecasted $1.06. Revenue for the quarter reached $64.92 million, surpassing the anticipated $63.95 million.
Market reaction
Despite the better-than-expected financial results, the stock moved lower in after-hours trading. Orrstown Financial Services' shares closed at $34.57, a decline of 4.08% on the trading day. These price movements reflect investor and market responses following the earnings release.
Context for stakeholders
These developments - the insider sale, the retained holding and restricted shares, and the companyâs quarterly outperformance coupled with a negative after-hours reaction - provide a set of facts investors and analysts can weigh as they assess Orrstown's near-term outlook. The companyâs ability to top consensus in both EPS and revenue is a notable data point, while the share-price decline in after-hours trading signals a mixed reception from the market.
Ongoing evaluation
Analysts and investors continue to evaluate Orrstown Financial Services based on these recent disclosures and results. The combination of insider activity, the timing of restricted-share vesting, and the divergence between reported results and immediate market reaction are items market participants will monitor as part of their assessment of the firmâs financial health and valuation.